Skip to content
GenoLensGenoLens

MYOD1

Chr 11p15.1

myogenic differentiation 1

Aliases:
PUM, MYOD, bHLHc1
MANE:
ENST00000250003.4

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Congenital myopathy

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Arthrogryposis

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • myopathy, congenital, with diaphragmatic defects, respiratory insufficiency, and dysmorphic facies

    0.68
  • neurodegenerative disease

    0.46
  • rhabdomyosarcoma

    0.44
  • Hodgkins lymphoma

    0.39
  • spindle cell rhabdomyosarcoma

    0.37
  • embryonal rhabdomyosarcoma

    0.37
  • fetal akinesia deformation sequence

    0.37
  • cecum adenocarcinoma

    0.37
  • gastric carcinoma

    0.37
  • gastric adenocarcinoma

    0.37

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Myoblast determination protein 1

Acts as a transcriptional activator that promotes transcription of muscle-specific target genes and plays a role in muscle differentiation. Together with MYF5 and MYOG, co-occupies muscle-specific gene promoter core region during myogenesis. Induces fibroblasts to differentiate into myoblasts. Interacts with and is inhibited by the twist protein. This interaction probably involves the basic domains of both proteins (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.